Metri, Prashant K and Naz, Sarwat and Kondaiah, Paturu and Prasad, Kavirayani R (2013) MPK-09, a small molecule inspired from bioactive styryllactone restores the wild-type function of mutant p53. In: ACS Chemical Biology, 8 (7). pp. 1429-1434.
PDF
ACS_Chem_Biol_8-7_1429_2013.pdf - Published Version Restricted to Registered users only Download (524kB) | Request a copy |
|
PDF
ACS_Chem_Bio_8-7_1_2013.pdf - Published Supplemental Material Restricted to Registered users only Download (8MB) | Request a copy |
Abstract
In the search for more efficacious and less toxic cancer drugs, the tumor suppressor p53 protein has long been a desirable therapeutic target. In the recent past, few independent studies have demonstrated that the antitumor activity of wild-type p53 can be restored in cancer cells harboring mutant form of p53 using small molecule activators. In this study, we describe a novel small molecule MPK-09, which is selective and highly potent against allele specific p53 mutations mainly, R175H, R249S, R273H, R273C, and E285K. Except E285K, all other mutations tested are among the six ``hot spot'' p53 mutations reported in majority of human cancer. Furthermore, our study conclusively demonstrates that the apoptotic activity of the small molecule MPK-09 against cancer cells harboring R273C and E285K mutations is due to restoration of the wild-type conformation to the corresponding mutant form of p53.
Item Type: | Journal Article |
---|---|
Publication: | ACS Chemical Biology |
Publisher: | American Chemical Society |
Additional Information: | Copyright of this article belongs to American Chemical Society. |
Department/Centre: | Division of Biological Sciences > Molecular Reproduction, Development & Genetics Division of Chemical Sciences > Organic Chemistry |
Date Deposited: | 01 Oct 2013 11:30 |
Last Modified: | 01 Oct 2013 11:30 |
URI: | http://eprints.iisc.ac.in/id/eprint/47443 |
Actions (login required)
View Item |